BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28285783)

  • 1. Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.
    Walker D; Susa JS; Currimbhoy S; Jacobe H
    J Am Acad Dermatol; 2017 Jun; 76(6):1124-1130. PubMed ID: 28285783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of self-reported quality of life in adults and children with morphea.
    Das S; Bernstein I; Jacobe H
    J Am Acad Dermatol; 2014 May; 70(5):904-10. PubMed ID: 24534655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and histopathologic changes of morphea: A single-center, retrospective study of 137 patients.
    Kim J; Chung KB; Lee YI; Kim J; Lee JH
    J Am Acad Dermatol; 2021 Jul; 85(1):105-113. PubMed ID: 33188871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin mapping for the classification of generalized morphea.
    Teske N; Welser J; Jacobe H
    J Am Acad Dermatol; 2018 Feb; 78(2):351-357. PubMed ID: 29332706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.
    Prasad S; Black SM; Zhu JL; Sharma S; Jacobe H
    J Am Acad Dermatol; 2021 Jul; 85(1):114-120. PubMed ID: 33249064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature.
    Dhaliwal CA; MacKenzie AI; Biswas A
    J Cutan Pathol; 2014 Jan; 41(1):28-35. PubMed ID: 24117981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Disease Activity and Damage Over Time in Patients With Morphea.
    O'Brien JC; Nymeyer H; Green A; Jacobe HT
    JAMA Dermatol; 2020 May; 156(5):513-520. PubMed ID: 32236501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation of the Performance of Current Morphea Subtype Classifications.
    Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
    JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
    Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H
    J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.
    Condie D; Grabell D; Jacobe H
    Arthritis Rheumatol; 2014 Dec; 66(12):3496-504. PubMed ID: 25156342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.
    Grabell D; Hsieh C; Andrew R; Martires K; Kim A; Vasquez R; Jacobe H
    J Am Acad Dermatol; 2014 Sep; 71(3):493-8. PubMed ID: 24880663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between quality of life and clinical characteristics in patients with morphea.
    Bali G; Kárpáti S; Sárdy M; Brodszky V; Hidvégi B; Rencz F
    Qual Life Res; 2018 Oct; 27(10):2525-2532. PubMed ID: 29922914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
    Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
    JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
    Johnson W; Jacobe H
    J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphea and its variants and the "floating sign"-an additional finding in morphea.
    Perez-Chua TA; Kisel YG; Chang KH; Bhawan J
    Am J Dermatopathol; 2014 Jun; 36(6):500-5. PubMed ID: 23823027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keloid morphea and nodular scleroderma: two distinct clinical variants of scleroderma?
    Rencic A; Brinster N; Nousari CH
    J Cutan Med Surg; 2003; 7(1):20-4. PubMed ID: 12362259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic Spectrum of Morphea.
    Chiu YE; Abban CY; Konicke K; Segura A; Sokumbi O
    Am J Dermatopathol; 2021 Jan; 43(1):1-8. PubMed ID: 33337624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial.
    Liu J; Wang J; Zhang Q; Lu F; Cai J
    JAMA Dermatol; 2024 Apr; 160(4):425-433. PubMed ID: 38324287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.